Sam­sung and San­doz ques­tion FDA's 're­search roadmap' for biosim­i­lars de­vel­op­ment

The FDA last Jan­u­ary asked biosim­i­lar de­vel­op­ers and oth­er stake­hold­ers to com­ment on up­com­ing plans for new biosim­i­lar-re­lat­ed re­search. Over the last two weeks, biosim­i­lar …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER